News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
129,795 Results
Type
Article (4309)
Company Profile (88)
Press Release (125398)
Multimedia
Podcasts (3)
Webinars (6)
Section
Business (42072)
Career Advice (211)
Deals (6155)
Drug Delivery (13)
Drug Development (17411)
Employer Resources (18)
FDA (1486)
Job Trends (2781)
News (66190)
Policy (3647)
Tag
2024 BioCapital Digital (2)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (3)
2024 Biotech Bay Standard (5)
2024 Biotech Beach Digital (7)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (6)
2024 Genetown Standard (3)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (4)
2025 Lone Star Bio Digital (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Genetown Standard (1)
2026 Pharm Country Standard (1)
Academia (292)
Adcomms (1)
Allergies (16)
Alliances (11465)
ALS (28)
Alzheimer's disease (328)
Antibody-drug conjugate (ADC) (29)
Approvals (1500)
Artificial intelligence (49)
Autoimmune disease (12)
Automation (4)
Bankruptcy (38)
Best Places to Work (2249)
BIOSECURE Act (14)
Biosimilars (8)
Biotechnology (85)
Bladder cancer (21)
Brain cancer (6)
Breast cancer (69)
Cancer (551)
Cardiovascular disease (17)
Career advice (200)
Career pathing (5)
CAR-T (59)
Cell therapy (168)
Cervical cancer (6)
Clinical research (14127)
Collaboration (258)
Compensation (114)
Complete response letters (2)
COVID-19 (429)
CRISPR (9)
C-suite (103)
Cystic fibrosis (27)
Data (578)
Depression (8)
Diabetes (50)
Diagnostics (694)
Digital health (1)
Diversity, equity & inclusion (8)
Drug discovery (43)
Drug pricing (5)
Drug shortages (2)
Duchenne muscular dystrophy (20)
Earnings (12516)
Editorial (4)
Employer resources (18)
Events (24697)
Executive appointments (271)
FDA (1724)
Featured Employer (13)
Frontotemporal dementia (5)
Funding (226)
Gene editing (23)
Generative AI (4)
Gene therapy (82)
GLP-1 (111)
Government (344)
Guidances (9)
Healthcare (1525)
Huntington's disease (6)
IgA nephropathy (7)
Immunology and inflammation (23)
Indications (10)
Infectious disease (458)
Inflammatory bowel disease (51)
Inflation Reduction Act (1)
Influenza (17)
Intellectual property (36)
Interviews (18)
IPO (2932)
IRA (4)
Job creations (666)
Job search strategy (186)
Kidney cancer (2)
Labor market (9)
Layoffs (38)
Legal (639)
Liver cancer (12)
Lung cancer (42)
Lymphoma (56)
Management (4)
Manufacturing (87)
MASH (10)
Medical device (399)
Medtech (399)
Mergers & acquisitions (3418)
Metabolic disorders (117)
Multiple sclerosis (24)
NASH (1)
Neurodegenerative disease (16)
Neuropsychiatric disorders (3)
Neuroscience (452)
NextGen: Class of 2025 (858)
Non-profit (275)
Northern California (819)
Now hiring (6)
Obesity (60)
Opinion (37)
Ovarian cancer (29)
Pain (20)
Pancreatic cancer (23)
Parkinson's disease (39)
Partnered (4)
Patents (57)
Patient recruitment (28)
Peanut (12)
People (16462)
Pharmaceutical (8)
Phase I (5597)
Phase II (6751)
Phase III (3459)
Pipeline (314)
Policy (26)
Postmarket research (209)
Preclinical (2404)
Press Release (51)
Prostate cancer (19)
Psychedelics (2)
Radiopharmaceuticals (46)
Rare diseases (66)
Real estate (1444)
Recruiting (10)
Regulatory (2963)
Reports (13)
Research institute (298)
Resumes & cover letters (20)
RSV (4)
Schizophrenia (12)
Series A (41)
Series B (29)
Service/supplier (2)
Sickle cell disease (11)
Southern California (749)
Special edition (1)
Spinal muscular atrophy (36)
Sponsored (4)
Startups (984)
State (1)
Stomach cancer (2)
Supply chain (18)
Tariffs (5)
The Weekly (3)
United States (6199)
Vaccines (77)
Venture capitalists (7)
Weight loss (22)
Women's health (4)
Worklife (2)
Date
Today (25)
Last 7 days (175)
Last 30 days (675)
Last 365 days (8713)
2025 (2648)
2024 (9148)
2023 (9882)
2022 (12008)
2021 (12647)
2020 (9863)
2019 (6677)
2018 (5282)
2017 (6073)
2016 (5595)
2015 (6446)
2014 (4924)
2013 (4062)
2012 (4401)
2011 (4873)
2010 (4517)
Location
Africa (137)
Alabama (30)
Alaska (1)
Arizona (26)
Arkansas (2)
Asia (8482)
Australia (1993)
California (1895)
Canada (542)
China (108)
Colorado (29)
Connecticut (68)
Delaware (25)
Europe (18497)
Florida (175)
Georgia (27)
Idaho (10)
Illinois (123)
India (4)
Indiana (94)
Iowa (1)
Japan (34)
Kansas (11)
Kentucky (2)
Louisiana (1)
Maine (2)
Maryland (214)
Massachusetts (1373)
Michigan (68)
Minnesota (96)
Missouri (8)
Montana (8)
Nebraska (2)
Nevada (4)
New Hampshire (5)
New Jersey (412)
New Mexico (6)
New York (452)
North Carolina (270)
North Dakota (3)
Northern California (819)
Ohio (39)
Oklahoma (5)
Oregon (5)
Pennsylvania (377)
Puerto Rico (3)
Rhode Island (5)
South America (201)
South Carolina (1)
Southern California (749)
Tennessee (15)
Texas (219)
Utah (18)
Virginia (13)
Washington D.C. (8)
Washington State (322)
Wisconsin (6)
129,795 Results for "siren biotechnology".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Siren Biotechnology Expands Clinical and Scientific Advisory Board with Key Industry Leaders
March 6, 2025
·
4 min read
Business
Siren Biotechnology and Catalent Enter Partnership for Manufacturing of AAV Gene Therapies for Cancer
Siren Biotechnology, pioneers of Universal AAV Immuno-Gene Therapy for Cancer, and Catalent Inc., the leader in enabling the development and supply of better treatments for patients worldwide, entered a strategic partnership to support the development and manufacturing of Siren Biotechnology’s AAV immuno-gene therapies.
May 8, 2024
·
2 min read
Genetown
MilliporeSigma Announces Siren Biotechnology as Winner of its North American Advance Biotech Grant
MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, announced that Siren Biotechnology has been selected as the North American winner of its 13th Advance Biotech Grant Program.
June 4, 2024
·
5 min read
Press Releases
Siren Biotechnology Reveals SRN-101 as Lead Asset for High-Grade Gliomas with Both Orphan Drug and Rare Pediatric Disease Designations from the FDA
November 18, 2024
·
2 min read
Biotech Bay
Siren Biotechnology Awarded $4M in Grant Funding from the California Institute for Regenerative Medicine (CIRM)
Siren Biotechnology announced that the California Institute for Regenerative Medicine has awarded the company a $4M translational research grant to support the development of novel AAV immuno-gene therapies for cancer.
November 1, 2023
·
2 min read
Biotech Bay
Siren Biotechnology Launches to Pioneer Universal AAV Immuno-Gene Therapy™ for Cancer
Siren Biotechnology, pioneers of Universal AAV Immuno-Gene Therapy, a revolutionary new treatment modality for cancer, launched out of stealth concurrent with its first preclinical data presentation at the ASGCT 26th Annual Meeting, taking place in Los Angeles, May 16-20th.
May 17, 2023
·
7 min read
Drug Development
Siren Biotechnology Unveils Preclinical Data for Universal AAV Immuno-Gene Therapy™ for Cancer, a Novel Modality that Combines AAV Gene Therapy and Cytokine Immunotherapy
Siren Biotechnology announced the presentation of preclinical data demonstrating the effect of a novel treatment for cancer, Universal AAV Immuno-Gene Therapy, which combines AAV gene therapy and cytokine immunotherapy into a single modality.
May 17, 2023
·
4 min read
Press Releases
New tool for cutting DNA: promising prospects for biotechnology
April 15, 2025
·
4 min read
Press Releases
Momentum Biotechnologies Announces Acquisition of OmicScouts
March 5, 2025
·
4 min read
Press Releases
Puma Biotechnology to Host Conference Call to Discuss First Quarter 2025 Financial Results
April 25, 2025
·
2 min read
1 of 12,980
Next
